ATTAIN demonstrated placebo-adjusted weight reductions of roughly 9–11 percentage points at 72 weeks, with 27.3 lb (12.4%) ...

From teledermatology billing to rural outreach and transplant advances, new studies and presentations reveal shifts in access ...

Overall, mammography prevalence declined from 69.9% to 59.2% among women aged 40 to 49 years and from 81.3% to 77.0% in women ...

HB 4965 permits switching to an alternative medically appropriate treatment of equal or lesser value after initial approval, ...

The CDC announced on April 1 that they would be downsizing their operations, leading to the pause of diagnostic testing for mpox, rabies, and more than 2 dozen other infectious diseases. 1 The CDC has ...

Collapsing the very-low-risk category reflects broader acceptance of active surveillance for Gleason 6 disease, while PARP ...

Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack ...

“Interestingly, BIRC5 and MCL-1 have both been reported to be over-expressed and strongly correlated with progression and ...

Price variation does not just occur across markets and services; it also emerges between networks and providers.

Building on insights from last year, experts across sessions at the 2026 American Academy of Dermatology (AAD) Annual Meeting ...

Lauren Madigan, MD, shares open-label extension results demonstrating sustained improvements with avapritinib in patients ...

Combining traditional dermatopathology with PCR-based molecular testing improves diagnostic accuracy in differentiating ...